Skip to content

Clinical trials

Diabetic Neuropathies trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20103
20111
20121
20131
20141
20151
20164
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital3
GL Pharm Tech Corporation2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Seoul National University2
Bukwang Pharmaceutical1
Chonbuk National University Hospital1
Dong-A Pharmaceutical Co., Ltd.1
Dong-A ST Co., Ltd.1
Eli Lilly and Company1
Helixmith Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies16
Neuralgia6
Neuralgia, Postherpetic5
Peripheral Nervous System Diseases2
Complex Regional Pain Syndromes1
Diabetic Foot1
Failed Back Surgery Syndrome1
Hypesthesia1
Paresthesia1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.